MedTrace Logo

Opt-IVF Multi-center Trial 2 Including All Protocols

NCT05981898 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 550

Last updated 2024-07-17

No results posted yet for this study

Summary

A multi-center randomized clinical trial is proposed to study the effectiveness of the advanced decision support tool Opt-IVF for ALL PROTOCOLS in reducing medication, testing, and improving outcomes.

Conditions

  • IVF

Interventions

DEVICE

OPTIVF dosage

Dosage predicted by Opt-IVf

DEVICE

traditional Dosage

Dosage used traditionally by doctors

Sponsors & Collaborators

  • Indira IVF, India

    collaborator UNKNOWN

  • Stochastic Research Technologies LLC

    lead INDUSTRY

Principal Investigators

  • Urmila Diwekar · Stochastic Research Technologies LLC/University of Illinois at Chicago

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-09-15
Primary Completion
2024-03-15
Completion
2024-04-15

Countries

  • India

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05981898 on ClinicalTrials.gov